Provocative test with propofol: Experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures

American Journal of Neuroradiology

Volumn 31, Issue 3, 2010, Pages 470-475

  Feliciano, Caleb E ^a   De Leon Berra R ^a   Hernandez Gaitan M S ^a   Torres, H M ^b   Creagh, O ^b   Rodriguez Mercado R ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; ENBUCRILATE; ETHIODIZED OIL; ETIRACETAM; FENTANYL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; LEVOTHYROXINE SODIUM; MIDAZOLAM; PHENYTOIN; PROPOFOL; PSYCHOTROPIC AGENT; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARM WEAKNESS; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; CHILD; CLINICAL ARTICLE; COIL EMBOLIZATION; DIAGNOSTIC VALUE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DYSARTHRIA; FEMALE; HUMAN; MALE; NEUROLOGIC EXAMINATION; PARESIS; SCHOOL CHILD; SEDATION; WADA TEST;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; CEREBRAL ANGIOGRAPHY; CHILD; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRA-ARTERIAL; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPOFOL; YOUNG ADULT;

EID: 77949498032     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1855     Document Type: Article

References (19)

1. Fournier D, TerBrugge KG, Willinsky R, et al. Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases. J Neurosurg 1991;75:228-33
2. Hurst RW, Berenstein A, Kupersmith MJ, et al. Deep central arteriovenous malformations of the brain: the role of endovascular treatment. J Neurosurg 1995;82:190-95
3. Mounayer C, Hammami N, Piotin M, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 2007;28:518-23
4. Valavanis A, Yaçsargil MG. The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 1998;24:131-214
5. Yu SC, Chan MS, Lam JM, et al. Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure. AJNR Am J Neuroradiol 2004;25:1139-43
6. Barr JD, Mathis JM, Horton JA. Provocative pharmacologic testing during arterial embolization. Neurosurg Clin N Am 1994;5:403-11
7. Buchtel HA, Passaro EA, Selwa LM, et al. Sodium methohexital (Brevital) as an anesthetic in the Wada test. Epilepsia 2002;43:1056-61
8. Kim JH, Joo EY, Han SJ, et al. Can pentobarbital replace amobarbital in the Wada test? Epilepsy Behav 2007;11:378-83
9. Jones-Gotman M, Sziklas V, Djordjevic J, et al. Etomidate speech and memory test (eSAM): a new drug and improved intracarotid procedure. Neurology 2005;65:1723-29
10. Silva TM, Hernández-Fustes OJ, Bueno ML, et al. The Wada test with propofol in a patient with epilepsy. Arq Neuropsiquiatr 2000;58:348-50
11. Takayama M, Miyamoto S, Ikeda A, et al. Intracarotid propofol test for speech and memory dominance in man. Neurology 2004;63:510-15
12. Fitzsimmons BF, Marshall RS, Pile-Spellman J, et al. Neurobehavioral differences in superselectiveWadatesting with amobarbital versus lidocaine. AJNR Am J Neuroradiol 2003;24:1456-60
13. Mikuni N, Takayama M, Satow T, et al. Evaluation of adverse effects in intracarotid propofol injection for Wada test. Neurology 2005;65:1813-16
14. Barash PG, Cullen BF, Stoelting RK, et al. Handbook of Clinical Anesthesia. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009:1093, 1110
15. Aids to the Examination of the Peripheral Nervous System. Medical Research Council. London: Her Majesty's Stationary Office, 1976.
16. Niimi Y, Sala F, Deletis V, et al. Neurophysiologic monitoring and pharmacologic provocative testing for embolization of spinal cord arteriovenous malformations. AJNR Am J Neuroradiol 2004;25:1131-38
17. Grote CL, Meador K. Has amobarbital expired? Considering the future of the Wada. Neurology 2005;65:1692-93
18. Malerba G, Romano-Girard F, Cravoisy A, et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 2005;31:388-92
19. Kotani Y, Shimazawa M, Yoshimura S, et al. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther 2008:14:95-106